Companies
Colossal Biosciences
three living dire wolves (Romulus, Remus, Khaleesi) edited from gray wolves; mammoth program (~85 elephant-gene edits, 2028 birth target), thylacine, dodo and bluebuck programs; Colossal BioVault and World Preservation Lab for genetic-material storage.
- Country
- United States
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| monitoring-conservation | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $615M total raised capital | colossal.com |
| Production site | 55,000-square-foot headquarters and laboratory in Dallas, Texas | colossal.com · dmagazine.com |
| Production site | 2,000-acre ecological preserve for dire wolves at an undisclosed location in the United States | colossal.com |
| Certification | American Humane Certification for dire wolf facility and research protocols | colossal.com |
| Regulatory approval | USDA Animal Welfare Act compliance and registration | colossal.com |
| Headcount | 266 employees as of July 20, 2026 | tipranks.com |
| Revenue | Company started generating revenue over the last year (as of July 2026) medium confidence | techcrunch.com |
| Revenue | $27.5M in 2024 revenue medium confidence | upmarket.co |
| Capacity | Somatic cell nuclear transfer lab performs 200 to 300 cellular transfers per day | colossal.com · dmagazine.com |
Independent sources: dmagazine.com · techcrunch.com · tipranks.com · upmarket.co
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| De-extinction & conservation biotech | monitoring-conservation | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.